Human monoclonal antibodies show promise as treatment and prevention for influenza B
Researchers at Vanderbilt University Medical Center (VUMC) have made a significant breakthrough by isolating human monoclonal antibodies against influenza B. This virus is a notable public health threat, particularly affecting children, the elderly, and individuals with weakened immune systems. While seasonal flu vaccines provide coverage against both influenza A and B, they do not always … Read more